Junichi Hatanaka

Title: Junichi Hatanaka: Innovator in Pharmaceutical Formulations

Introduction

Junichi Hatanaka is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. His work has led to advancements that benefit both the industry and patients.

Latest Patents

Hatanaka holds a patent for "Methods for producing aripiprazole suspension and freeze-dried formulation." This patent discloses a method for producing an aripiprazole suspension, where the aripiprazole has a mean particle size of 1 to 10 µm. The method involves several steps, including combining bulk aripiprazole with a vehicle to form a primary suspension, subjecting it to first pulverization, and then creating a sterile final suspension through second pulverization. This innovative approach enhances the efficacy and stability of the medication.

Career Highlights

Hatanaka is associated with Otsuka Pharmaceutical Company, Limited, where he has been instrumental in developing new pharmaceutical formulations. His expertise in the field has led to the successful implementation of his patented methods in the production of aripiprazole, a medication used to treat various mental health conditions.

Collaborations

Throughout his career, Hatanaka has collaborated with esteemed colleagues such as Shogo Hiraoka and Takakuni Matsuda. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Junichi Hatanaka's contributions to pharmaceutical formulations, particularly through his patent on aripiprazole suspension, highlight his role as a key innovator in the industry. His work continues to impact the field positively, paving the way for future advancements in medication development.